BUSATO, DAVIDE

BUSATO, DAVIDE  

Dipartimento di Scienze della Vita  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.169 secondi).
Titolo Data di pubblicazione Autori File
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 1-gen-2023 Busato, DavideCapolla, SaraDurigutto, PaoloMossenta, MonicaBozzer, SaraSblattero, DanieleMacor, PaoloToffoli, Giuseppe +
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients 1-gen-2021 Bedon L.Mossenta M.Busato D.Toffoli G. +
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies 1-gen-2020 Monica MossentaDavide BusatoGiuseppe Toffoli +
Glypican 1-targeted therapeutic approaches adopting doxorubicin-loaded chitosan nanobubbles and antibody-based strategy in the context of Pancreatic Ductal Adenocarcinoma 19-set-2022 BUSATO, DAVIDE
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma 1-gen-2025 Mossenta MCapolla SDAVIDE BUSATODurigutto PMangogna ASblattero DMacor PToffoli G +
New insight into therapies targeting angiogenesis in hepatocellular carcinoma 1-gen-2019 Monica MossentaDavide BusatoFederica Di CintioGiuseppe Toffoli +
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells. 1-gen-2024 Federica Di CintioScomparin ACapolla SBusato DSteffè AMangogna ASblattero DMacor PToffoli G +